An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens

NCT00000935 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

NIH

Sponsor class

Conditions

End-Stage Renal Disease
Kidney Transplantation

Interventions

BIOLOGICAL: Intravenous immune globulin (IVIG)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)